Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment

Baijin Xia(Sun Yat-sen University), Bingfeng Liu(Harbin Institute of Technology)
Molecular Therapy — Oncolytics
July 27, 2023
Cited by 32


Related Papers